Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation
- PMID: 12151430
- DOI: 10.1093/humrep/17.8.2016
Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation
Abstract
Background: The effect of LH levels on stimulation day 8 on ovarian response and pregnancy outcome were evaluated in women receiving pituitary down-regulation with GnRH agonists (0.8 mg Suprefact) s.c. daily until pituitary down-regulation and 0.4 mg/day during ovarian stimulation) and ovarian stimulation with recombinant FSH.
Methods: Blood samples were prospectively collected from a total of 207 normal women undergoing assisted reproduction and analysed retrospectively. Based on LH levels on stimulation day 8 patients were divided into four groups: <0.5, 0.51-1.0, 1.01-1.5, >1.51 IU/l.
Results: Estradiol levels on day 8 and estradiol per oocyte retrieved showed a highly significant correlation with LH concentrations on day 8. The total consumption of exogenous FSH and duration of gonadotrophin stimulation was inversely related to LH levels on day 8 (P < 0.002). The frequencies of fertilization and clinical pregnancies were superior in the two middle groups. Only 12% of the patients showed LH levels <0.5 IU/l, which, however, may be explained by the particular mode and doses of GnRH agonist used.
Conclusions: Circulating levels of LH on day 8 have a significant impact on ovarian response and pregnancy outcome. LH should neither be too high nor too low. The mode of administration and the dose of the GnRH agonist used may determine the number of women who experience LH levels below 0.5 IU/l.
Similar articles
-
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953. J Clin Endocrinol Metab. 2003. PMID: 12970285 Clinical Trial.
-
A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.Hum Reprod. 2006 Oct;21(10):2645-9. doi: 10.1093/humrep/del219. Epub 2006 Jun 19. Hum Reprod. 2006. PMID: 16785261
-
LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.Hum Reprod. 2003 Dec;18(12):2689-97. doi: 10.1093/humrep/deg506. Hum Reprod. 2003. PMID: 14645193
-
Outlook: who needs LH in ovarian stimulation?Reprod Biomed Online. 2006 May;12(5):599-607. doi: 10.1016/s1472-6483(10)61186-8. Reprod Biomed Online. 2006. PMID: 16790105 Review.
-
Role of LH and FSH in ovarian function.Mol Cell Endocrinol. 2000 Mar 30;161(1-2):25-30. doi: 10.1016/s0303-7207(99)00219-1. Mol Cell Endocrinol. 2000. PMID: 10773387 Review.
Cited by
-
The ratio of late-follicular to mid-follicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH.J Assist Reprod Genet. 2008 Aug;25(8):359-64. doi: 10.1007/s10815-008-9243-0. Epub 2008 Aug 28. J Assist Reprod Genet. 2008. PMID: 18752065 Free PMC article.
-
Effects of Low Luteinizing Hormone During Ovarian Stimulation on Endometrial Gene Expression and Function - Transcriptome Analysis During the Implantation Window.Reprod Sci. 2022 Jun;29(6):1908-1920. doi: 10.1007/s43032-022-00875-5. Epub 2022 Feb 15. Reprod Sci. 2022. PMID: 35170000
-
Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer.Front Endocrinol (Lausanne). 2019 Sep 18;10:639. doi: 10.3389/fendo.2019.00639. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31620091 Free PMC article.
-
Luteinizing hormone supplementation in women with hypogonadotropic hypogonadism seeking fertility care: Insights from a narrative review.Front Endocrinol (Lausanne). 2022 Aug 1;13:907249. doi: 10.3389/fendo.2022.907249. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35979440 Free PMC article. Review.
-
Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between patients with different ovarian responses (a STROBE-compliant article).Medicine (Baltimore). 2019 Jul;98(27):e16191. doi: 10.1097/MD.0000000000016191. Medicine (Baltimore). 2019. PMID: 31277126 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources